![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: HS3ST1 |
Gene summary for HS3ST1 |
![]() |
Gene information | Species | Human | Gene symbol | HS3ST1 | Gene ID | 9957 |
Gene name | heparan sulfate-glucosamine 3-sulfotransferase 1 | |
Gene Alias | 3OST | |
Cytomap | 4p15.33 | |
Gene Type | protein-coding | GO ID | GO:0006022 | UniProtAcc | A0A024R9R4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9957 | HS3ST1 | LZE8T | Human | Esophagus | ESCC | 3.07e-09 | 6.58e-01 | 0.067 |
9957 | HS3ST1 | LZE20T | Human | Esophagus | ESCC | 7.32e-05 | 4.63e-01 | 0.0662 |
9957 | HS3ST1 | LZE24T | Human | Esophagus | ESCC | 2.66e-05 | 4.10e-01 | 0.0596 |
9957 | HS3ST1 | P1T-E | Human | Esophagus | ESCC | 2.79e-06 | 1.15e+00 | 0.0875 |
9957 | HS3ST1 | P2T-E | Human | Esophagus | ESCC | 4.16e-07 | 2.80e-01 | 0.1177 |
9957 | HS3ST1 | P4T-E | Human | Esophagus | ESCC | 1.85e-07 | 5.67e-02 | 0.1323 |
9957 | HS3ST1 | P5T-E | Human | Esophagus | ESCC | 4.34e-04 | 4.07e-02 | 0.1327 |
9957 | HS3ST1 | P8T-E | Human | Esophagus | ESCC | 8.80e-56 | 1.85e+00 | 0.0889 |
9957 | HS3ST1 | P10T-E | Human | Esophagus | ESCC | 1.23e-13 | 1.69e-01 | 0.116 |
9957 | HS3ST1 | P11T-E | Human | Esophagus | ESCC | 3.31e-06 | 4.47e-01 | 0.1426 |
9957 | HS3ST1 | P12T-E | Human | Esophagus | ESCC | 3.32e-06 | 1.08e-02 | 0.1122 |
9957 | HS3ST1 | P16T-E | Human | Esophagus | ESCC | 1.56e-21 | 5.62e-01 | 0.1153 |
9957 | HS3ST1 | P23T-E | Human | Esophagus | ESCC | 2.37e-31 | 1.32e+00 | 0.108 |
9957 | HS3ST1 | P26T-E | Human | Esophagus | ESCC | 7.86e-05 | 1.50e-02 | 0.1276 |
9957 | HS3ST1 | P27T-E | Human | Esophagus | ESCC | 3.71e-10 | 1.50e-01 | 0.1055 |
9957 | HS3ST1 | P30T-E | Human | Esophagus | ESCC | 1.74e-05 | 1.76e-01 | 0.137 |
9957 | HS3ST1 | P32T-E | Human | Esophagus | ESCC | 3.79e-04 | 3.57e-02 | 0.1666 |
9957 | HS3ST1 | P37T-E | Human | Esophagus | ESCC | 1.98e-13 | 1.34e-01 | 0.1371 |
9957 | HS3ST1 | P39T-E | Human | Esophagus | ESCC | 1.84e-09 | 3.24e-01 | 0.0894 |
9957 | HS3ST1 | P40T-E | Human | Esophagus | ESCC | 6.52e-03 | 2.01e-02 | 0.109 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0006024 | Esophagus | ESCC | glycosaminoglycan biosynthetic process | 45/8552 | 75/18723 | 8.75e-03 | 3.08e-02 | 45 |
GO:0006023 | Esophagus | ESCC | aminoglycan biosynthetic process | 47/8552 | 79/18723 | 9.29e-03 | 3.23e-02 | 47 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HS3ST1 | SNV | Missense_Mutation | c.888N>A | p.Phe296Leu | p.F296L | O14792 | protein_coding | tolerated(0.1) | probably_damaging(1) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD | |
HS3ST1 | SNV | Missense_Mutation | c.578N>A | p.Arg193His | p.R193H | O14792 | protein_coding | deleterious(0.01) | probably_damaging(0.922) | TCGA-B5-A11N-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
HS3ST1 | SNV | Missense_Mutation | novel | c.892G>A | p.Glu298Lys | p.E298K | O14792 | protein_coding | tolerated(0.27) | benign(0.01) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
HS3ST1 | SNV | Missense_Mutation | novel | c.760N>C | p.Phe254Leu | p.F254L | O14792 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
HS3ST1 | SNV | Missense_Mutation | novel | c.82C>G | p.Gln28Glu | p.Q28E | O14792 | protein_coding | tolerated(1) | benign(0) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
HS3ST1 | SNV | Missense_Mutation | rs779505564 | c.256N>A | p.Glu86Lys | p.E86K | O14792 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
HS3ST1 | SNV | Missense_Mutation | novel | c.113A>G | p.Gln38Arg | p.Q38R | O14792 | protein_coding | tolerated(0.48) | benign(0.011) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
HS3ST1 | SNV | Missense_Mutation | c.364G>A | p.Ala122Thr | p.A122T | O14792 | protein_coding | deleterious(0.01) | probably_damaging(0.959) | TCGA-EO-A3AU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
HS3ST1 | SNV | Missense_Mutation | c.454N>T | p.Arg152Cys | p.R152C | O14792 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-SJ-A6ZI-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
HS3ST1 | SNV | Missense_Mutation | novel | c.247N>T | p.Ala83Ser | p.A83S | O14792 | protein_coding | deleterious(0.03) | probably_damaging(0.999) | TCGA-2Y-A9H4-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |